Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Authors
Keywords
-
Journal
ACTA NEUROPATHOLOGICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-11
DOI
10.1007/s00401-019-02020-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
- (2018) Antoine Forget et al. CANCER CELL
- Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
- (2018) Tenley C. Archer et al. CANCER CELL
- Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial
- (2018) Tobias Goschzik et al. LANCET ONCOLOGY
- Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
- (2017) Edward C Schwalbe et al. LANCET ONCOLOGY
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures
- (2017) E. C. Schwalbe et al. Scientific Reports
- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Class probability estimation for medical studies
- (2014) Richard Simon BIOMETRICAL JOURNAL
- Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
- (2014) Paul A. Northcott et al. NATURE
- DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
- (2013) Edward C. Schwalbe et al. ACTA NEUROPATHOLOGICA
- Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
- (2013) Volker Hovestadt et al. ACTA NEUROPATHOLOGICA
- A comprehensive overview of Infinium HumanMethylation450 data processing
- (2013) S. Dedeurwaerder et al. BRIEFINGS IN BIOINFORMATICS
- Subgroup-Specific Prognostic Implications ofTP53Mutation in Medulloblastoma
- (2013) Nataliya Zhukova et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- Molecular subgroups of medulloblastoma
- (2012) Paul A Northcott et al. Expert Review of Neurotherapeutics
- Subgroup-specific structural variation across 1,000 medulloblastoma genomes
- (2012) Paul A. Northcott et al. NATURE
- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
- (2011) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
- (2011) Paul A. Northcott et al. ACTA NEUROPATHOLOGICA
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials
- (2009) Barry L. Pizer et al. BRITISH JOURNAL OF NEUROSURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started